Biocept to Release First Quarter 2020 Financial Results and Host Investor Conference Call on May 13, 2020

29 Apr 2020 - Yahoo News
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will release financial results for the three months ended March 31, 2020 ...
usx:bioc

---

Biocept Announces CE-IVD Mark and Availability of its Target Selector™ EGFR Molecular Assay Kit in Europe

28 Apr 2020 - Yahoo News
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the award of CE (Conformité Européene)-IVD Mark for its Target Selector™ molecular ...
usx:bioc

---

Biocept Launches Unique Line of Molecular Assay Kits for Detection of Key Oncogene Mutations Based on its Proprietary Target Selector™ Technology Validated for Use in Both Tissue and Blood Samples

20 Apr 2020 - Yahoo News
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the availability of research-use-only (RUO) kits that can allow molecular laboratories ...
usx:bioc

---

Biocept Announces Pricing of $10.3 Million Registered Direct Offering Priced At-The-Market

14 Apr 2020 - Yahoo News
Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, today announced that on April 14, 2020 it ...
usx:bioc

---

Biocept to Begin COVID-19 Testing

9 Apr 2020 - Yahoo News
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it has verified a COVID-19 molecular diagnostic test, and plans to begin accepting ...
usx:bioc

---

Brazil Patent Granted for Biocept's Target Selector™ Oncogene Mutation Enrichment and Detection Platform

9 Apr 2020 - Yahoo News
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it has been granted Brazil Patent No. BR112013028296-7, titled, METHODS FOR ...
usx:bioc

---

Australia Patent Issued for Primer-Switch Mutation Detection and Amplification Platform

2 Apr 2020 - Yahoo News
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it has been granted Australia Patent number: 2017268486, titled, METHODS FOR ...
usx:bioc

---

For Penny Investors, Biocept Stock Makes a Good Speculative Play

1 Apr 2020 - Yahoo News
Is there room left right now to talk about healthcare companies not connected in any way to a COVID-19 test, vaccine or treatment? Let’s try.Over the past 3 years, Biocept (BIOC) stock has been punished to the tune of a mighty 99.50% decline. Unsurprisingly, the stock is extremely cheap, with each share ...
usx:bioc

---

US$1.00: That's What Analysts Think Biocept, Inc. (NASDAQ:BIOC) Is Worth After Its Latest Results

28 Mar 2020 - Yahoo News
It's been a good week for Biocept, Inc. (NASDAQ:BIOC) shareholders, because the company has just released its latest...
usx:bioc

---

Biocept Enters into Laboratory Services Agreement with Second California-Based Independent Physician Association

26 Mar 2020 - Yahoo News
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it has entered into an agreement with a second California-based independent ...
usx:bioc

---